Andrea Tubaro

Pubblicazioni

Titolo Pubblicato in Anno
Residents and Consultants Have Equal Outcomes When Performing Transrectal Fusion Biopsies: A Randomized Clinical Trial CURRENT ONCOLOGY 2024
Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries UROLOGY 2024
Quality of information and appropriateness of Open AI outputs for prostate cancer PROSTATE CANCER AND PROSTATIC DISEASES 2024
Yoga, benign prostatic hyperplasia and lower urinary tract symptoms: a new path for clinical trials PROSTATE CANCER AND PROSTATIC DISEASES 2024
Sexual and reproductive health: level of knowledge and source of information in adolescence JOURNAL OF SEXUAL MEDICINE 2024
Open versus Minimally Invasive Partial Nephrectomy: Trends and Outcomes from a Wide National Population-Based Database JOURNAL OF CLINICAL MEDICINE 2024
Renal Function Preservation in Purely Off-Clamp Sutureless Robotic Partial Nephrectomy: Initial Experience and Technique DIAGNOSTICS 2024
Purely Off-Clamp Sutureless Robotic Partial Nephrectomy for Novice Robotic Surgeons: A Multi-Institutional Propensity Score-Matched Analysis JOURNAL OF CLINICAL MEDICINE 2024
Trends and incidence of reported events associated with ureteral stents: an analysis of the food and drug administration's manufacturer and user facility device experience (MAUDE) database WORLD JOURNAL OF UROLOGY 2024
Post-Voided Residual Ratio Does Not Predict Trifecta Outcome after Transurethral Resection of Prostate LIFE 2024
Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH PROSTATE CANCER AND PROSTATIC DISEASES 2024
Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database MINERVA UROLOGY AND NEPHROLOGY 2024
Evaluation of peri-operative outcomes after prostatic urethral lift with emphasis on urodynamic changes, symptom improvement and sexual function DIAGNOSTICS 2024
No clinical benefit from sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) than BCG alone in the adjuvant treatment of high risk non muscle invasive bladder cancer: result of a planned interim analysis of a prospective randomized trial MINERVA UROLOGY AND NEPHROLOGY 2024
Patients’ Preferences and Expectations in Overactive Bladder: A Systematic Review JOURNAL OF CLINICAL MEDICINE 2023
Inflammation and Prostate Cancer: Pathological Analysis from Pros-IT CNR 2 CANCERS 2023
Physical Inactivity, Metabolic Syndrome and Prostate Cancer Diagnosis: Development of a Predicting Nomogram METABOLITES 2023
Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries PROSTATE CANCER AND PROSTATIC DISEASES 2023
Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram CLINICAL GENITOURINARY CANCER 2023
Medications mostly associated with hematuria: assessment of the EudraVigilance and Food and Drug Administration pharmacovigilance databases entries MINERVA UROLOGY AND NEPHROLOGY 2023

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma